Focus Middle East and India

Chief Scientific Officer Dr. Baumann on FOCUS’ offering for Indian pharmaceutical companies

In a recent road-show FOCUS’ Managing Director and Chief Scientific Officer Dr. Matthias Baumann reported on the specific development challenges and business opportunities for Indian pharmaceuticals in European markets. He presented this information at various pharmaceutical and biotechnological operations in India. We are pleased to offer a complimentary copy of this presentation for your personal use. Please feel free to [...]

FOCUS bridging services for established and emerging markets

Globalisation and presence in emerging markets worldwide is key to future growth of the bio-pharmaceutical industry. FOCUS offers bridging expertise with 25 bridging studies completed in the past 5 years. Find further detailed information by clicking on the following link: brochure on FOCUS bridging studies

Free documentation: Success factors to achieve EU pharma product registration

Western markets offer significant business opportunities for Indian pharmaceuticals. Thus, Indian pharma companies look for smart approaches towards product registration in western markets, such as in the EU or in the US, via EMEA or FDA, respectively. FOCUS Clinical Drug Development GmbH (FOCUS-CDD) has many years of successful experience with EMEA and FDA submissions and registrations. [...]

Development of Indian Pharmaceuticals for Western Markets

The Indian pharmaceutical industry has made great progress and moved up the value chain from generics to discovery based R&D.  FOCUS wants to serve the Indian pharmaceutical industry and be their partner in the unique opportunity of developing new compounds, bridging India to Europe and major Western markets. FOCUS Clinical Drug Development GmbH (www.focus-cdd.de) is an [...]